Benzquinamide

Systematic (IUPAC) name

3-(Diethylcarbamoyl)-9,10-dimethoxy-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-yl acetate
Clinical data
Trade names	Promecon, Quantril, Emete-Con
Licence data	US FDA:link
Routes of administration	Suppository, injection
Identifiers
CAS Registry Number	63-12-7^Y
ATC code	None
DrugBank	DB00767^N
ChemSpider	2252^N
UNII	0475EA27Q3^Y
KEGG	D00243^N
ChEMBL	CHEMBL1201250^N
Chemical data
Formula	C₂₂H₃₂N₂O₅
Molecular mass	404.5 g/mol
SMILES CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(=O)C
InChI InChI=InChI=1S/C22H32N2O5/c1-6-23(7-2)22(26)17-13-24-9-8-15-10-20(27-4)21(28-5)11-16(15)18(24)12-19(17)29-14(3)25/h10-11,17-19H,6-9,12-13H2,1-5H3 ^N Key:JSZILQVIPPROJI-UHFFFAOYSA-N ^N
N (what is this?) (verify)

Benzquinamide is a discontinued antiemetic drug used in post-operative care. It was first synthesised by Pfizer in the 1960s.^[1]^[2]

References

↑ Scriabine et al. (1963). J. Am. Med. Assoc. 184: 276. Missing or empty |title= (help)
↑ E.I. Goldenthal (1971). "A compilation of LD50 values in newborn and adult animals". Toxicol. Appl. Pharmacol. 18 (1): 185–207. doi:10.1016/0041-008X(71)90328-0. PMID 5542824.